Award
NIH Reporter #5U01CA271279-06
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
Recipient
ADVENTHEALTH ORLANDO
Award Amount
$1,229,874.00
Ceiling
$1,229,874.00
Awarded
August 10, 2026
Identifier
5U01CA271279-06
Award for a study on the effects of aerobic exercise during chemotherapy in colon cancer patients, focusing on chemotherapy tolerability and immune biomarkers.
Description
This project aims to evaluate the dose-response effects of aerobic exercise on chemotherapy tolerability and related outcomes in colon cancer survivors. The study involves adaptive randomization and multiple aims including assessment of tissue distribution and immune biomarkers.